Park Avenue Securities’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
PL
LWAM
QCM
DC
AI
Park Avenue Securities's GMAB Position: Q2 2026 in Review
Park Avenue Securities reduced its Genmab (GMAB) stake by 28% in Q2 2026, selling an estimated $116K and leaving 10,993 shares worth $302K. The position accounts for ﹤0.01% of the portfolio, ranked #1525.
Park Avenue Securities first reported a position in GMAB in Q4 2020 and has held it in 22 quarters since. The position peaked at $583K in Q3 2023. 77 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.
- Park Avenue Securities held 10,993 shares of Genmab worth $302K as of Q2 2026.
- Park Avenue Securities sold 4,371 Genmab shares in Q2 2026, an estimated $116K.
- Genmab made up ﹤0.01% of Park Avenue Securities's portfolio in Q2 2026, its #1525 holding.
- Park Avenue Securities first reported a position in Genmab in Q4 2020 and has held it in 22 quarters since.
- Park Avenue Securities's Genmab position peaked at $583K in Q3 2023.
- 77 funds tracked by Wall St. Rank held Genmab as of Q2 2026.
Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.